BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9709269)

  • 41. An overview of mammography: benefits and limitations.
    Smith RA
    J Natl Compr Canc Netw; 2003 Apr; 1(2):264-71. PubMed ID: 19768884
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer screening methods: a review of the evidence.
    Vahabi M
    Health Care Women Int; 2003 Nov; 24(9):773-93. PubMed ID: 14742116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mass screening of breast cancer: response and justification].
    Bartsch P; Gordenne W
    Rev Med Liege; 1998 Apr; 53(4):214-5. PubMed ID: 9641017
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammography screening for breast cancer.
    King JM
    Cancer; 1994 Apr; 73(7):2003-6. PubMed ID: 8137231
    [No Abstract]   [Full Text] [Related]  

  • 46. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
    Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
    Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening mammography: increasing the effort toward breast cancer detection.
    Hamwi DA
    Nurse Pract; 1990 Dec; 15(12):27, 30-2. PubMed ID: 2284059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mammography screening methods and diagnostic results.
    Thurfjell E
    Acta Radiol Suppl; 1995; 395():1-22. PubMed ID: 7839866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
    Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
    Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer screening outcomes in women ages 40-49: clinical experience with service screening using modern mammography.
    Sickles EA
    J Natl Cancer Inst Monogr; 1997; (22):99-104. PubMed ID: 9709284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-cost mass screening with mammography as a means of reducing overall mortality from breast cancer.
    McLelland R
    Radiol Clin North Am; 1987 Sep; 25(5):1007-13. PubMed ID: 3306771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Screening for breast cancer: the time of decision].
    Gordenne W
    J Belge Radiol; 1998 Apr; 81(2):92-5. PubMed ID: 9640877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation.
    Ulloa-Pérez E; Mohar-Betancourt A; Reynoso-Noverón N
    Rev Invest Clin; 2016; 68(4):184-91. PubMed ID: 27623037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening younger women at risk for breast cancer.
    Vogel VG
    J Natl Cancer Inst Monogr; 1994; (16):55-60. PubMed ID: 7999470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-cost screening mammography: report on finances and review of 21,716 consecutive cases.
    Bird RE
    Radiology; 1989 Apr; 171(1):87-90. PubMed ID: 2494683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost evaluation of breast cancer screening in France.
    Lamarque JL; Pujol J; Cherifcheikh J; Laurent JC; Taourel P; Boulet P; Daurès JP; Séguret F; Guizard AV; Delande G; Negre M
    Acad Radiol; 1998 Sep; 5 Suppl 2():S336-9. PubMed ID: 9750847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.